Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1453 participants.

Also called NCT01240902

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,453 participants (enrolled count) (from the registry)
Sponsor
  • Medtronic Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01240902
Other papers using this trial's data
  • 2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery Journal of the American College of Cardiology, 2015-09-22 DOI, PubMed 26383718
  • 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement Journal of the American College of Cardiology, 2015-07-14 DOI, PubMed 26055947
  • 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement Journal of the American College of Cardiology, 2016-06-07 DOI, PubMed 27050187
  • 5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients Journal of the American College of Cardiology, 2018-12-04 DOI, PubMed 30249462
  • Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement Journal of the American College of Cardiology, 2016-01-05 DOI, PubMed 26764063, PMC4959424 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Early Recovery of Left Ventricular Systolic Function After CoreValve Transcatheter Aortic Valve Replacement Circulation. Cardiovascular interventions, 2016-06 DOI, PubMed 27296201
  • Effect of Baseline Aortic Regurgitation on Mortality in Patients Treated With Transcatheter or Surgical Aortic Valve Replacement (from the CoreValve US Pivotal Trial) The American journal of cardiology, 2018-11-01 DOI, PubMed 30172363
  • Five-Year Health Status After Self-expanding Transcatheter or Surgical Aortic Valve Replacement in High-risk Patients With Severe Aortic Stenosis JAMA cardiology, 2021-01-01 DOI, PubMed 32997095, PMC7527937 Not in the PMC Open Access subset.
  • Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial JACC. Cardiovascular interventions, 2015-08-17 DOI, PubMed 26292584, PMC4599371 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Impact of Stroke Volume Index and Left Ventricular Ejection Fraction on Mortality After Aortic Valve Replacement Mayo Clinic proceedings, 2020-01 DOI, PubMed 31902431
  • Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less JAMA cardiology, 2016-11-01 DOI, PubMed 27541162
  • Predicting Early and Late Mortality After Transcatheter Aortic Valve Replacement Journal of the American College of Cardiology, 2016-07-26 DOI, PubMed 27443429
  • Regression of Paravalvular Aortic Regurgitation and Remodeling of Self-Expanding Transcatheter Aortic Valve: An Observation From the CoreValve U.S. Pivotal Trial JACC. Cardiovascular imaging, 2015-12 DOI, PubMed 26508386
  • Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction Circulation. Cardiovascular interventions, 2016-06 DOI, PubMed 27313280
  • Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgery The Journal of thoracic and cardiovascular surgery, 2014-12 DOI, PubMed 25152474

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01240902. Randomized; no masking; primary purpose treatment. Start 2010-12-10 (actual); primary completion 2014-08 (actual). Results posted on 2015-06-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement
Condition
Severe Aortic Stenosis
Intervention (Device)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Intervention (Device)
Surgical Aortic Valve Replacement (SAVR)
Lead sponsor
Medtronic Cardiovascular (class: industry)

Record details

Record id
cardio:ct-nct01240902
Content hash
f29697baa9ec51029f6f68329908c6fc5fc92fc5dddf69b6532e64f87d2c767b